Since medulloblastoma is a childhood cancer that occurs during development and maturation of the nervous system, we also assessed whether Gmnn inhibition could be used to selectively target cancer cells without affecting nervous system development or neurological function. This evidence concerns the gene GMNN and medulloblastoma.